One of the most distinctive features of human sweet taste perception is its broad tuning to chemically diverse compounds ranging from low-molecular-weight sweeteners to sweet-tasting proteins. Many reports suggest that the human sweet taste receptor (hT1R2–hT1R3), a heteromeric complex composed of T1R2 and T1R3 subunits belonging to the class C G protein–coupled receptor family, has multiple binding sites for these sweeteners. However, it remains unclear how the same receptor recognizes such diverse structures. Here we aim to characterize the modes of binding between hT1R2–hT1R3 and low-molecular-weight sweet compounds by functional analysis of a series of site-directed mutants and by molecular modeling–based docking simulation at the binding pocket formed on the large extracellular amino-terminal domain (ATD) of hT1R2. We successfully determined the amino acid residues responsible for binding to sweeteners in the cleft of hT1R2 ATD. Our results suggest that individual ligands have sets of specific residues for binding in correspondence with the chemical structures and other residues responsible for interacting with multiple ligands.
Citation: Masuda K, Koizumi A, Nakajima K-i, Tanaka T, Abe K, Misaka T, et al. (2012) Characterization of the Modes of Binding between Human Sweet Taste Receptor and Low-Molecular-Weight Sweet Compounds. PLoS ONE 7(4): e35380. doi:10.1371/journal.pone.0035380
Editor: Wolfgang Meyerhof, German Institute for Human Nutrition, Germany
Received: August 22, 2011; Accepted: March 16, 2012; Published: April 20, 2012
Copyright: © 2012 Masuda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was performed with a grant from the Research and Development Program for New Bio-industry Initiatives of the Bio-oriented Technology Research Advancement Institution. This work was also supported by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (to AK) and by Grants-in-aid for Scientific Research 21880015 (to KN), 20688015 and 21658046 (to TM) and 20380183 (to KA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The human sweet taste receptor (hT1R2–hT1R3) is a heteromeric complex composed of two subunits, T1R2 and T1R3, which are class C G protein–coupled receptors (GPCRs) , , . Each subunit has a large amino-terminal domain (ATD) linked by an extracellular cysteine-rich domain (CRD) to a seven-transmembrane helical domain (TMD) . hT1R2–hT1R3 responds to a wide variety of chemical substances including naturally occurring sugars (glucose, sucrose, fructose and sugar alcohols), D-amino acids (D-tryptophan and D-phenylalanine) and glycosides (stevioside and glycyrrhizin), as well as artificial chemical compounds such as sucralose, aspartame, neotame, saccharin Na, acesulfame K (AceK), and cyclamate (Fig. 1) . Moreover, naturally occurring sweet proteins, such as brazzein, thaumatin, and monellin, and naturally occurring taste-modifying proteins, such as neoculin and miraculin, also bind to hT1R2–hT1R3 , , , , , . hT1R2–hT1R3 has multiple ligand-binding sites for these various sweeteners. For example, the ATD of hT1R2 is responsible for binding to aspartame and sugar derivatives . Neoculin binds the ATD of hT1R3 . In contrast, cyclamate and neohesperidin dihydrochalcone (NHDC) bind the TMD of hT1R3 as agonists , whereas this region also serves as the allosteric binding site for saccharin and lactisole as antagonists .
The structural features of the ATD of the homodimeric metabotropic glutamate type 1 receptor (mGluR1) have been identified by X-ray crystal structure analysis, and this was the first example to reveal the structure of a class C GPCR . The ATD of mGluR1 comprises two lobes (LB1 and LB2) that form the glutamate-binding domain lying between LB1 and LB2. The structure of ATD exists in an equilibrium of two different conformations, and the structural change strongly depends on glutamate binding. In the ligand-free state, both LB1 and LB2 tend to show open conformations (open-open), whereas an agonist induces a closed conformation for LB1 and LB2 of one ATD, while the other remains in an open conformation. This closed-open structure is thought to contribute to the active state of mGluR1 .
Because hT1R2 and hT1R3 share sequence homology (24% and 23%) with mGluR1 (Fig. S1), they also share some common structural features with mGluR1 . hT1R2–hT1R3 can form a heterodimer, with the open-open form representing an inactive structure and the closed-open form representing an active structure. When low-molecular-weight sweeteners are applied, hT1R2 probably exhibits a closed conformation because the ATD of hT1R2 receives aspartame and sugar derivatives , . Not only these small sweeteners but also cyclic sulfamate derivatives such as saccharin sodium and AceK probably bind at the cleft formed by LB1 and LB2 of hT1R2 ATD; they differ from each other in their hydrophobicity, electric charge, molecular size and other parameters (Fig. 1). Naturally occurring hydrophilic sugars are generally different in chemical structure from rather hydrophobic artificial amino acid derivatives and cyclic sulfamate derivatives. Moreover, amino acid derivatives and cyclic sulfamate derivatives have charged groups, whereas sugar derivatives are neutral.
Several ligand-binding sites were proposed by a molecular modeling–based docking simulation for the sweet taste receptor , , , , . Thus, the wedge site of an open form of the ATD of the T1R3 was proposed for sweet proteins , , , whereas the involvement of the CRD of the T1R3 was proposed for brazzein, a sweet protein . On the other hand, the cavity of the closed form formed by LB1 and LB2 of either T1R2 or T1R3 ,  is suggested for small sweeteners as glutamate bound in the glutamate receptor . In this study, we found that the various structures of low-molecular-weight sweeteners were recognized by the sweet taste receptor hT1R2–hT1R3 through the different residues at the ligand-binding site of the ATD of T1R2. Modes of binding between hT1R2–hT1R3 and low-molecular-weight sweet chemical substances were characterized both by response profiles of cells expressing the mutated hT1R2–hT1R3 to sweeteners and by a molecular modeling–based docking simulation at the binding cleft formed by LB1 and LB2 of hT1R2. The candidate amino acid residues at the binding cleft of hT1R2 were targeted to produce mutated hT1R2, which was then heterologously expressed in cultured cells together with hT1R3 and its coupling Gα protein. Using the functional analysis of cell-based assays, we successfully determined the residues responsible for binding to each sweetener in the ligand-binding cleft of hT1R2 ATD and found that individual molecules use characteristic residues for binding. A mechanism of receptor activation is also discussed according to a molecular model of the receptor–ligand complex.
Materials and Methods
Site-directed mutagenesis of hT1R2 cDNA
cDNA fragments with point mutations in hT1R2 were synthesized by the overlap PCR method using mutated primer pairs. The following 15 residues in hT1R2 were mutated individually to Ala: S40, K65, Y103, D142, S144, S165, Y215, P277, D278, Y282, E302, S303, D307, E382, and R383. In the cases of Y103, D142, Y215, P277, and R383, each residue was also replaced with residues other than Ala (Y103F, D142R, Y215F, P277G, P277Q, P277S, R383D, R383Q, R383L, and R383H).
Calcium imaging analysis of the heterologously transfected cultured cells
cDNA fragments were subcloned into the pEAK10 vector (Edge Biosystems, Gaithersburg, MD, USA). Each hT1R2 mutant was transiently cotransfected together with hT1R3 and G16-gust44  into HEK293T cells (kindly provided by Dr. Hiroaki Matsunami, Duke University), and calcium imaging analysis was carried out as described previously . Briefly, transfected cells were seeded into 96-well Lumox multiwell black-wall plates (SARSTEDT AG & Co., Nümbrecht, Germany). After 40–46 hours, the cells were loaded with 5 µM of fura-2/AM (Invitrogen, Carlsbad, CA, USA) in assay buffer for 30 min at 37°C, and then washed with assay buffer, prior to incubation in 100 µl of assay buffer for more than 10 min at room temperature. The cells were stimulated with sweet tastants by adding 100 µl of 2× ligands. The intensities of fura-2 fluorescence emissions resulting from excitation at 340 and 380 nm were measured at 510 nm using a CCD camera. The images were recorded at 4 sec intervals and analyzed using MetaFluor software (Molecular Devices, Sunnyvale, CA, USA).
Construction of stable cell lines expressing the mutated human sweet taste receptor
The entire coding regions of hT1R2, hT1R3, and G16-gust44 were subcloned into the pcDNA5/FRT vector (Invitrogen) according to the procedure described previously . To generate the expression plasmid for the mutated receptor, the hT1R2 cDNA fragment with the point mutation was used instead of using the wild-type (WT) hT1R2 cDNA.
Stable cell lines expressing mutant hT1R2 together with hT1R3 and G16-gust44 were generated to prepare the following hT1R2 mutants: Y103A, Y103F, D142A, S144A, S165A, P277A, P277G, P277S, P277Q, D278A, E302A, D307A, E382A, and R383H. The stable cell lines were generated using Flp-In 293 cells (Invitrogen) and the plasmid we constructed according to the manufacturer's protocol for the Flp-In pcDNA5/FRT Complete System (Invitrogen) as described in our previous publication . Hygromycin-resistant cells were collected, cultured, and used to measure the cellular responses to sweet tastants. The cells for these measurements were cultured in low-glucose (1.0 g/l) Dulbecco's modified Eagle's medium with 10% fetal bovine serum.
Measurement of cellular responses by the cell-based assay
Trypsinized cells were seeded at a density of 80,000 cells per well into 96-well black-wall CellBIND surface plates (Corning, Corning, NY, USA) and 24 hours later were washed with assay buffer prior to loading with a calcium indicator dye from the FLIPR Calcium 4 Assay Kit (Molecular Devices) diluted with assay buffer. The cells were incubated for 60 min at 37°C, and measurements were made using FlexStation 3 (Molecular Devices) at 37°C. Fluorescence changes by excitation at 485 nm, emission at 525 nm, and cutoff at 515 nm were monitored at 2 s intervals, an aliquot of 100 µl of assay buffer supplemented with 2× ligands was added at 20 s, and scanning was continued for an additional 100 s. The response of each well was represented as ΔRFU (delta relative fluorescence unit) and defined as maximum fluorescence value minus minimum fluorescence value. To calculate EC50 values, plots of amplitude versus concentration were prepared in Clampfit Version 9.2 (Molecular Devices). Nonlinear regression of the plots produced the function:where x is the ligand concentration and h is the Hill coefficient used to calculate the EC50 values for ligand–receptor interactions. When the EC50 value of the mutated receptor-expressing cells was changed more than 5 fold compared with wild type receptor, the corresponding mutation was judged to be largely affected.
Structure modeling of receptor and receptor–ligand complexes
The crystal structures of the ATD of mGluR1 solved in both inactive (glutamate-unbound) and active (glutamate-bound) forms (PDB: 1EWT and 1EWK, respectively) were used to construct the ATDs of hT1R2 and hT1R3. The structural model of the ATDs of the hT1R2 and hT1R3 heterodimer was constructed with homology modeling according to their sequence homology with mGluR1. For the active form of the heterodimer model, the closed form of mGluR1 was used for hT1R2 and the open form for hT1R3. Conversely, the open form of the crystal structure of mGluR1 was used to construct the inactive form of T1R2 and T1R3. Each heterodimeric structure was then energy-minimized with molecular mechanics using Discover 3 (Accelrys Inc., CA, USA), and the main chain was tethered at the conserved position.
Sweet small ligands were docked into the ligand-binding cleft of the hT1R2 model where glutamate is bound in the mGluR1; this was pursuant to the plausible interactions between the charged or hydrophilic groups of the ligands and the receptor that were deduced from the mutational experiments. Conformations of the ligands were then generated and energy-minimized with molecular mechanics using Discover 3. The minimized complex structures were then structure-optimized with molecular dynamics using Discover 3, and the residues were tethered beyond 12 Å from the ligands.
Mutagenesis studies for screening the residues responsible for sweetener recognition
To define the binding modes of sweeteners at the cleft formed by LB1 and LB2 of hT1R2 ATD, we carried out a series of mutagenesis studies on hT1R2 ATD. First, a molecular model of hT1R2 ATD based on the ligand-binding structure of the closed form of mGluR1 was constructed. Based on the residues resided in the glutamate-binding cleft in the structure of mGluR1 ATD, 15 residues of hT1R2 were arbitrarily selected to introduce the point mutation (Fig. S1, Table S1), and 25 single hT1R2 mutants for the 15 residues were then constructed. The selected residues were almost hydrophilic, and were expected to form ionic or hydrogen bonds with the ligands. The responses to sweeteners were examined by a calcium imaging assay using HEK293T cells transiently expressing the T1R2 mutant and T1R3. Ten out of the 15 residues (Y103, D142, S144, S165, P277, D278, E302, D307, E382, and R383) were selected from the results of the 25 mutants because receptors mutated at these 10 residues retained the responsiveness and exhibited largely changed activities toward the sweeteners tested (Table S1).
As for the 10 residues, stable cell lines expressing the hT1R2 mutant and hT1R3 were constructed, and the cell-based assay was performed to determine the dose–response relationship with the half-maximal effective concentration (EC50) value for each sweetener. To validate the activity of each mutated receptor, we used an artificial sweetener cyclamate, which was recognized by the TMD of hT1R3, as positive controls . Because all the hT1R2 mutant cell lines clearly responded to cyclamate, showing similar EC50 values to those expressing the WT receptor (Table 1), the mutated receptors were determined to be functionally expressed. The response profiles of the mutated receptors to the sweeteners are summarized in Table 1.
Residues responsible for aspartame and D-tryptophan reception in hT1R2 ATD
The response to aspartame was completely lost in the cell lines expressing E302A, S144A, D142A and Y103A (Fig. 2A), and EC50 values largely increased in those expressing D278A, with a decrease in potency (EC50 value 8.14-fold increase versus WT, Fig. 2B). These results suggest that the residues E302, S144, D142, Y103, and D278 are crucial for aspartame reception, among which E302 and S144 have also been previously reported as important residues for aspartame recognition .
Responses of the stable cell lines to aspartame (A, B) and d-Trp (C, D) were determined by the cell based assay. The mutations introduced into hT1R2 subunit are shown. Each point indicates the mean ± S.E.M. from at least 3 independent experiments.
In contrast, only the application of d-tryptophan (d-Trp) to E302A-expressing cells elicited no response (Fig. 2C), and large increases in EC50 values were observed for D307A, D142A, D278A, S165A, Y103A, and P277A mutants (>5-fold increase versus WT) (Fig. 2D and Table 1). Although aspartame elicited no response in D142A and Y103A mutants (Fig. 2A and Table 1), d-Trp considerably reduced the response potency to these mutants within an 8-fold EC50 increase (Fig. 2D and Table 1). In the cases of S165A and P277A mutants, EC50 of d-Trp increases 5.40- and 6.31-fold, respectively (Fig. 2D), while those of aspartame were only changed (Table 1). Although the carboxylate of aspartame and d-Trp is located near S165 and R383 in their complex models, the carboxylate of d-Trp would interact with S165, but that of aspartame would be located at slightly different position not to directly interact with S165. A similar case is also the interactions of P277 with d-Trp and aspartame, in which the indole moiety is locate closer to P277 than the phenylalanine moiety is. The roles of S165 and P277 in receptor activation are thus ligand depended.
Residues responsible for saccharin Na and acesulfame K reception in hT1R2 ATD
Saccharin Na and AceK activated WT hT1R2–hT1R3 in a dose-dependent manner at lower concentrations, but the response was suppressed at higher concentrations (>3 mM and >10 mM, respectively, Figs. 3A and 3B), which has been observed and investigated in detail by Galindo-Cuspinera et al. . Therefore, EC50 values for saccharin Na and AceK were estimated at the lower concentrations.
Responses of the stable cell lines expressing to saccharin Na (A) and AceK (B) were determined by the cell based assay, and the results of the cells expressing WT and hT1R2 mutants (D142A, R383H, and E382A) receptor are shown. Each point indicates the mean ± S.E.M. from at least 3 independent experiments.
The cellular responses to saccharin Na and AceK were lost in R383H, D142A and E382A (Figs. 3A and 3B). These results indicate that R383, D142, and E382 are crucial residues for activation by saccharin Na and AceK. The mutations E302, S144 and D278 scarcely affected the EC50 values for saccharin Na and AceK, unlike aspartame and d-Trp (Fig. 2 and Table 1). Moreover, the other mutations tested in this study were not sensitive to saccharin Na and AceK (Table 1), suggesting that the binding region for saccharin Na and AceK is limited to a region around R383 (see Discussion).
Residues responsible for sucralose reception in hT1R2 ATD
The response to sucralose was almost completely lost in D278A and Y103A (Fig. 4A). E302A, D307A, D142A, and P277A largely increased the EC50 values of sucralose and decreased the potency (Fig. 4B). Most of the crucial residues for sucralose reception (E302, D142, Y103, D278, and D307) appeared to overlap with those for d-Trp and aspartame reception (Table 1). However, unlike aspartame, the EC50 value of sucralose for S144A did not change dramatically (0.27 mM), and P277A elicited a remarkable increase of the EC50 value. These results indicate that sucralose partially shares the binding region with aspartame, but also interacts with sucralose-specific residue such as P277.
The results of the cells expressing WT and hT1R2 mutants (D278A and Y103A) receptor are shown in A, and those of E302A, D307, D142A, and P277A mutants are shown in B. Each point indicates the mean ± S.E.M. from at least 3 independent experiments.
Roles of Y103 and P277 at the entry of the lobes
Six out of the 10 critical residues (D142, D278, E302, D307, E382, and R383) are acidic or basic residues that probably bind to ligands via electrostatic interactions (Table 1). Furthermore, S144 and S165 were important for the reception of the amino acid derivatives aspartame and d-Trp, respectively (Figs. 2A and 2D). We next evaluated the role of the hydrophobic residues, Y103 and P277, located across the cleft of LB1 and LB2, respectively (See Discussion). To further examine the effect of Y103 on receptor activity, the responses of stable cell lines expressing additional mutants (in which Y103 was replaced with Phe in addition to Ala) were evaluated. When sucralose was applied to Y103 mutants, the response was almost completely lost in Y103A but was only slightly reduced in Y103F (Fig. 5A). These results indicate that the aromatic ring of Y103 is specifically essential to sucralose binding.
Dose-dependent responses of cells expressing Y103 mutants (Y103A and Y103F) to sucralose and P277 mutants (P277A, P277G, P277Q, and P277S) to aspartame are shown in A and B, respectively. Each point indicates the mean ± S.E.M. from at least 3 independent experiments.
To evaluate the role of P277, the additional mutants P277G, P277Q and P277S were constructed. The P277Q mutant showed severely reduced responses to aspartame (Fig. 5B) and d-Trp (Table 1), while P277G and P277S did not (Fig. 5B). In contrast, these three mutants responded almost equally to saccharin Na and AceK (Table 1). These results suggest that P277 plays an important role in allowing the sweet taste receptor to discriminate amino acid derivatives (aspartame and d-Trp) from the other sweeteners.
Critical residues for small molecular sweetener recognition in hT1R2 ATD
To clarify the roles of the 10 residues in small molecular sweetener recognition, we mapped them on the model of the open form of the hT1R2 ATD (Fig. 6). They were divided into four classes based on the results of a single point mutant analysis of hT1R2–hT1R3 corresponding to three chemically different types of ligands: amino acid derivatives (aspartame and d-Trp), sulfamates (saccharin Na and AceK), and a sugar analog (sucralose) (Table 1). Our data strongly suggest that the binding sites in hT1R2 ATD are quite different from each other, although all of them are recognized in the cleft of hT1R2 ATD. As shown in Figs. 7 and 8, aspartame, d-Trp, and sucralose share LB1 residues (Y103 and D142) and LB2 residues (D278, E302, and D307) for binding, but each compound also needs specific residues for individual interaction with the receptor (S144 for aspartame (Fig. 2A) and P277 for sucralose (Fig. 4B)). By contrast, these residues are not involved in binding saccharin Na and AceK, but the residues (D142, E382 and R383) located in another site of LB1 are indispensable for their binding (Figs. 6A).
(A) The 10 critical residues are mapped on the model as sticks. They were divided into four colors based on the results from the single point mutation analysis of hT1R2–hT1R3 using three chemically different types of ligands: amino acid derivatives (aspartame and d-Trp), sulfamates (saccharin Na and AceK), and a sugar analog (sucralose) (see also Table 1). Red: the three types of chemicals; pink: peptide derivatives and sucralose; purple: peptide derivative–specific; cyan: sulfamate-specific. (B) The model oriented 90° from (A).
(A) Complex model of sucralose in the closed form of hT1R2 ATD. Chlorine atoms are colored light green. (B) The model oriented 90° from (A). (C) Sucralose-binding pocket in detail (orange circle in (A)).
(A) Complex model of aspartame in the closed form of hT1R2 ATD. (B) The model oriented 90° from (A). (C) Aspartame-binding pocket in detail (orange circle in (A)).
The low-molecular-weight sweeteners bind in the cleft composed of LB1 and LB2 with a different binding mode at each characteristic residue. To examine further characteristic interactions between ligands and the 10 residues, we built ligand–hT1R2 ATD (closed form) complex models for sucralose, aspartame and saccharin Na (Figs. 7, 8, 9, Methods S1, S2, S3).
(A) Complex model of saccharin Na in the closed form of hT1R2 ATD. (B) The model oriented 90° from (A). (C) Saccharin Na–binding pocket in detail (orange circle in (A)). The sodium cation is illustrated by an orange ball.
(i) Roles of Y103 at the entry of LB1 and D278 at the entry of LB2
The complex models of sucralose–hT1R2 and aspartame–hT1R2 suggested different roles of Y103 in receptor activation. The C2-H and C4-Cl of the hexose portion of sucralose bind to the aromatic ring of Y103 (Fig. 7C), and the hydroxyl groups in the hexose moiety of sucralose form hydrogen bonds with D278 (Fig. 7C). The binding of the hexose portion to Y103 in LB1 and D278 in LB2 may thus facilitate the formation of the closed form of hT1R2 ATD. The importance of these residues for binding of sucralose is consistent with the results reported by Zhang et al. .
Conversely, the phenol group of Y103 forms a hydrogen bond with D278 in the aspartame–hT1R2 model (Fig. 8C), stabilizing the closed form of hT1R2. The hydrogen bond appears to be important for the d-Trp-binding. However, the role of the phenol group in the aspartame-binding would be more significant, since the phenol group would interact with the carboxylate of aspartame. The phenol group of Y103 is thus important for the binding of aspartame, while the aromatic group is necessary for the binding of sucralose, as in the cases of the Y103A and Y103F mutants (Fig. 5A). On the other hand, Zhang et al.  suggested a contribution of a hydrogen bond between D278 and K65 to the stabilization of the closed form in the binding of sweet taste enhancers. However, a transiently expressed K65A mutant receptor did not show a significant difference from the native receptor in the binding of aspartame and sucralose (Table S1), being consistent with the results reported by Zhang et al.  and Liu et al. , in which K65 is not important for the binding of aspartame and sugar derivatives.
(ii) Roles of E302 at the center of LB2
The negatively charged E302 residue forms a salt bond with the positively charged amine group of aspartame (Fig. 8C), whereas a hydroxyl group of the pentose moiety of sucralose forms a hydrogen bond with E302 (Fig. 7C). E302 in the LB2 should thus be a crucial residue for the ligands, with hydrogen bond donors contributing to the formation of the closed form in receptor activation. In contrast, the E302 residue makes no electrostatic interaction with saccharin Na (Fig. 9C), so the contribution of this residue to receptor activation should be little, if any (Fig. 3B).
(iii) Roles of D142, E382, and R383 at the center of LB1
Because R383 forms a hydrogen bond network with D142 and E382 in the hT1R2 model, R383 plays a crucial role in the recognition of negatively charged groups of ligands (Fig. 9C). D142 or E382 may not directly interact with the negatively charged ligands but would play an important role in localizing the flexible R383 residue at a proper position for interacting with the ligands (Fig. 9C). For aspartame recognition, binding of both the carboxylate moiety to R383 in LB1 and the amino group to E302 in LB2 may facilitate the formation of the closed form of the ATD (Fig. 8C). The negatively charged group of saccharin and the cationic sodium ion attached to saccharin would play similar roles in the formation of the closed form (Fig. 9C). Liu et al.  showed that S40 and V66 contribute to the species specificity in the binding of aspartame. The S40 residue is located at the hydrogen bond distance to D142 and the V66 residue is close to R383 in the aspartame-bound model. The mutation of these residues would electronically and sterically affect the interaction of D142 and R383 which are important for the recognition of the carboxylate of aspartame. This is somewhat similar to the roles of S40 and V66 in the species specific recognition of aspartame.
The neutral ligand sucralose may directly interact with D142 through a hydrogen bond with the vicinal hydroxyl groups of the furanose moiety (Fig. 7C). This hydrogen bond probably leads to the formation of a hydrogen bond between R383 and E302 to facilitate receptor activation.
(iv) Role of P277 at the entry of LB2
Aspartame and saccharin do not bind P277 (Figs. 7C and 8C). However, aspartame is located near the residue because the Gln mutant for P277 interrupts receptor activation by aspartame. In contrast, the mutation of smaller residues such as Gly and Ser does not affect activation (Fig. 7C). The smaller ligand, saccharin Na, may be located far from P277 and thus may not be influenced by the mutation (Fig. 9C). Still, P277 should be an important binding site for d-Trp, as observed in the P277A and P277Q mutants (Table 1). These results suggest that saccharin Na is located far from P277 whereas d-Trp is located close to P277. The distance between aspartame and P277 would be intermediate between those of saccharin Na and d-Trp.
The chloride at C1' of the furanose moiety of sucralose showed favorable van der Waals contact with P277 (Fig. 7C), and the P277Q mutant caused unfavorable steric interactions with the chloride; however, the favorable hydrophobic interactions are lost in the P277G and P277S mutants (Table 1).
Characteristic features in receptor activation mechanisms of the human sweet taste receptor
As described above, the interaction at the core of LB1 and LB2 appears to be essential for reception of all the sweeteners, and the interaction at the entry of LB1 and LB2 would reinforce the formation of the closed structure of the receptor for activation. These results strongly suggest that the activation mechanism of the human sweet taste receptor is similar to that of mGluR1.
X-ray crystal structural analysis, molecular modeling, and many mutagenesis studies have revealed the existence of critical residues for ligand binding in other class C GPCRs, such as mGluRs , , , the GABA receptor , , the calcium sensing receptor , , and the human umami taste receptor (hT1R1–hT1R3) . In comparison with previous data , our model of hT1R2–hT1R3 based on a mutagenesis analysis suggests that hT1R2–hT1R3 uses five acidic residues (D142, D278, E302, D307, or E382) for the recognition of its agonists; the other receptors use one or two acidic residues. These results suggest that hT1R2 ATD forms different sites of binding with specific sets of these residues to receive chemically diverse low-molecular-weight sweeteners, although their affinities for hT1R2 ATD are quite low.
It should be noted that we could not determine the binding mode of sugars such as sucrose. Sugars generally elicit the strong sweet taste, and they are the most common natural ligands for the receptor. Although it would be important to elucidate the key residues for the recognition of sugars, the cellular response to sucrose was quietly faint compared with the other sweeteners used in this study, and EC50 values of the mutated receptors to sucrose could not be accurately calculated. Further studies should be required to improve the sensitivity of the functional assay system for the human sweet taste receptor.
In this study, we defined how hT1R2–hT1R3 acquires the ability to recognize chemically diverse sweeteners. These results will not only provide insights into molecular recognition patterns of GPCRs but may also help develop novel sweeteners.
Summary of point mutations determined by a calcium imaging assay using HEK293T cells transiently expressing the T1R2 mutant and T1R3.
Sequence alignment of the ATDs of hT1R2 and rat mGluR1. The mutated residues in hT1R2 used for initial screening are shown in blue and magenta. Stable cell lines were also constructed for the residues shown in magenta. Critical ligand-binding residues in the rat mGluR1 ATD that interact with the carboxylate side chain and the α-amino acid moiety are shown in red and green, respectively.
Modeling for aspartame-T1R2ATD complex ( Fig. 8A–C ).
Conceived and designed the experiments: KM TT KA TM MI. Performed the experiments: KM AK KN MI. Analyzed the data: KM AK KN TM MI. Wrote the paper: AK TM MI.
- 1. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, et al. (2001) Mammalian sweet taste receptors. Cell 106: 381–390.
- 2. Li X, Staszewski L, Xu H, Durick K, Zoller M, et al. (2002) Human receptors for sweet and umami taste. Proc Natl Acad Sci U S A 99: 4692–4696.
- 3. Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, et al. (2003) The receptors for mammalian sweet and umami taste. Cell 115: 255–266.
- 4. Pin JP, Galvez T, Prezeau L (2003) Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther 98: 325–354.
- 5. Chandrashekar J, Hoon MA, Ryba NJ, Zuker CS (2006) The receptors and cells for mammalian taste. Nature 444: 288–294.
- 6. Temussi PA (2002) Why are sweet proteins sweet? Interaction of brazzein, monellin and thaumatin with the T1R2–T1R3 receptor. FEBS Lett 526: 1–4.
- 7. Jiang P, Ji Q, Liu Z, Snyder LA, Benard LM, et al. (2004) The cysteine-rich region of T1R3 determines responses to intensely sweet proteins. J Biol Chem 279: 45068–45075.
- 8. Walters DE, Hellekant G (2006) Interactions of the sweet protein brazzein with the sweet taste receptor. J Agric Food Chem 54: 10129–10133.
- 9. Cui M, Jiang P, Maillet E, Max M, Margolskee RF, et al. (2006) The heterodimeric sweet taste receptor has multiple potential ligand binding sites. Curr Pharm Des 12: 4591–4600.
- 10. Nakajima K, Asakura T, Oike H, Morita Y, Shimizu-Ibuka A, et al. (2006) Neoculin, a taste-modifying protein, is recognized by human sweet taste receptor. Neuroreport 17: 1241–1244.
- 11. Assadi-Porter FM, Maillet EL, Radek JT, Quijada J, Markley JL, et al. (2010) Key amino acid residues involved in multi-point binding interactions between brazzein, a sweet protein, and the T1R2–T1R3 human sweet receptor. J Mol Biol 398: 584–599.
- 12. Koizumi A, Nakajima K, Asakura T, Morita Y, Ito K, et al. (2007) Taste-modifying sweet protein, neoculin, is received at human T1R3 amino terminal domain. Biochem Biophys Res Commun 358: 585–589.
- 13. Winnig M, Bufe B, Kratochwil NA, Slack JP, Meyerhof W (2007) The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor. BMC Struct Biol 7: 66.
- 14. Galindo-Cuspinera V, Winnig M, Bufe B, Meyerhof W, Breslin PA (2006) A TAS1R receptor-based explanation of sweet ‘water-taste’. Nature 441: 354–357.
- 15. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, et al. (2000) Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971–977.
- 16. Morini G, Bassoli A, Temussi PA (2005) From small sweeteners to sweet proteins: anatomy of the binding sites of the human T1R2_T1R3 receptor. J Med Chem 48: 5520–5529.
- 17. Xu H, Staszewski L, Tang H, Adler E, Zoller M, et al. (2004) Different functional roles of T1R subunits in the heteromeric taste receptors. Proc Natl Acad Sci U S A 101: 14258–14263.
- 18. Zhang F, Klebansky B, Fine RM, Liu H, Xu H, et al. (2010) Molecular mechanism of the sweet taste enhancers. Proc Natl Acad Sci U S A 107: 4752–4757.
- 19. Walters DE (2002) Homology-based model of the extracellular domain of the taste receptor T1R3. Pure Appl Chem 74: 1117–1123.
- 20. Ueda T, Ugawa S, Yamamura H, Imaizumi Y, Shimada S (2003) Functional interaction between T2R taste receptors and G-protein alpha subunits expressed in taste receptor cells. J Neurosci 23: 7376–7380.
- 21. Imada T, Misaka T, Fujiwara S, Okada S, Fukuda Y, et al. (2010) Amiloride reduces the sweet taste intensity by inhibiting the human sweet taste receptor. Biochem Biophys Res Commun 397: 220–225.
- 22. Jiang P, Cui M, Zhao B, Snyder LA, Benard LM, et al. (2005) Identification of the cyclamate interaction site within the transmembrane domain of the human sweet taste receptor subunit T1R3. J Biol Chem 280: 34296–34305.
- 23. Liu B, Ha M, Meng XY, Kaur T, Khaleduzzaman M, et al. (2011) Molecular mechanism of species-dependent sweet taste toward artificial sweeteners. J Neurosci 31: 11070–11076.
- 24. Muto T, Tsuchiya D, Morikawa K, Jingami H (2007) Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc Natl Acad Sci U S A 104: 3759–3764.
- 25. Tsuchiya D, Kunishima N, Kamiya N, Jingami H, Morikawa K (2002) Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. Proc Natl Acad Sci U S A 99: 2660–2665.
- 26. Galvez T, Parmentier ML, Joly C, Malitschek B, Kaupmann K, et al. (1999) Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding. J Biol Chem 274: 13362–13369.
- 27. Galvez T, Prezeau L, Milioti G, Franek M, Joly C, et al. (2000) Mapping the agonist-binding site of GABAB type 1 subunit sheds light on the activation process of GABAB receptors. J Biol Chem 275: 41166–41174.
- 28. Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P, Krogsgaard-Larsen P (1999) The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 274: 18382–18386.
- 29. Hammerland LG, Krapcho KJ, Garrett JE, Alasti N, Hung BC, et al. (1999) Domains determining ligand specificity for Ca2+ receptors. Mol Pharmacol 55: 642–648.
- 30. Zhang F, Klebansky B, Fine RM, Xu H, Pronin A, et al. (2008) Molecular mechanism for the umami taste synergism. Proc Natl Acad Sci U S A 105: 20930–20934.
- 31. Wellendorph P, Brauner-Osborne H (2009) Molecular basis for amino acid sensing by family C G-protein-coupled receptors. Br J Pharmacol 156: 869–884.